10.19 USD
-0.01 (-0.1%)
10.17 USD
-0.02 (-0.2%)
THRN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. THRN has an average financial health and profitability rating. THRN shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
THRN had positive earnings in the past year.
In the past year THRN had a positive cash flow from operations.
1.2 Ratios
THRN's Return On Assets of 7.20% is fine compared to the rest of the industry. THRN outperforms 75.00% of its industry peers.
THRN's Return On Equity of 13.21% is fine compared to the rest of the industry. THRN outperforms 75.00% of its industry peers.
THRN's Return On Invested Capital of 4.69% is in line compared to the rest of the industry. THRN outperforms 55.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for THRN is significantly below the industry average of 11.83%.
The 3 year average ROIC (2.99%) for THRN is below the current ROIC(4.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROIC | 4.69% |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 7.94%, THRN is doing good in the industry, outperforming 70.00% of the companies in the same industry.
The Operating Margin of THRN (5.26%) is comparable to the rest of the industry.
THRN has a Gross Margin (50.15%) which is comparable to the rest of the industry.
THRN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), THRN is destroying value.
THRN has more shares outstanding than it did 1 year ago.
THRN has a worse debt/assets ratio than last year.
2.2 Solvency
THRN has an Altman-Z score of 3.41. This indicates that THRN is financially healthy and has little risk of bankruptcy at the moment.
THRN's Altman-Z score of 3.41 is fine compared to the rest of the industry. THRN outperforms 67.50% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that THRN is not too dependend on debt financing.
THRN has a Debt to Equity ratio (0.17) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.41 |
ROIC/WACC0.5
WACC9.44%
2.3 Liquidity
A Current Ratio of 2.41 indicates that THRN has no problem at all paying its short term obligations.
THRN's Current ratio of 2.41 is fine compared to the rest of the industry. THRN outperforms 70.00% of its industry peers.
A Quick Ratio of 1.13 indicates that THRN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.13, THRN perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 660.00% over the past year.
The Revenue has grown by 23.25% in the past year. This is a very strong growth!
The Revenue has been growing by 30.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
3.2 Future
The Earnings Per Share is expected to grow by 55.06% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 21.84% on average over the next years. This is a very strong growth
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 26.82, which means the current valuation is very expensive for THRN.
Based on the Price/Earnings ratio, THRN is valued a bit cheaper than 65.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.51. THRN is around the same levels.
A Price/Forward Earnings ratio of 16.38 indicates a correct valuation of THRN.
THRN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. THRN is cheaper than 77.50% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, THRN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as THRN.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.54 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
THRN's earnings are expected to grow with 55.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y46.48%
EPS Next 3Y55.06%
5. Dividend
5.1 Amount
No dividends for THRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.19
-0.01 (-0.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners0.03%
Inst Owner Change0%
Ins Owners10.68%
Ins Owner Change0%
Market Cap550.67M
Revenue(TTM)255.95M
Net Income(TTM)20.33M
Analysts80
Price Target8.61 (-15.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-40.77%
Min EPS beat(2)-112.25%
Max EPS beat(2)30.72%
EPS beat(4)2
Avg EPS beat(4)-25.45%
Min EPS beat(4)-112.25%
Max EPS beat(4)30.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)4.13%
Revenue beat(4)1
Avg Revenue beat(4)-4.4%
Min Revenue beat(4)-9.72%
Max Revenue beat(4)4.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.28%
PT rev (3m)20.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)5.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 | ||
| P/S | 2.15 | ||
| P/FCF | N/A | ||
| P/OCF | 25.59 | ||
| P/B | 3.58 | ||
| P/tB | 4.63 | ||
| EV/EBITDA | 28.54 |
EPS(TTM)0.38
EY3.73%
EPS(NY)0.62
Fwd EY6.11%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)0.4
OCFY3.91%
SpS4.74
BVpS2.85
TBVpS2.2
PEG (NY)1.87
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROCE | 5.95% | ||
| ROIC | 4.69% | ||
| ROICexc | 5.07% | ||
| ROICexgc | 6.08% | ||
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% | ||
| FCFM | N/A |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
ROICexc(3y)4.22%
ROICexc(5y)N/A
ROICexgc(3y)5.36%
ROICexgc(5y)N/A
ROCE(3y)3.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
F-Score5
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.31 | ||
| Cap/Depr | 590.87% | ||
| Cap/Sales | 14.33% | ||
| Interest Coverage | 19.78 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 3.41 |
F-Score5
WACC9.44%
ROIC/WACC0.5
Cap/Depr(3y)158.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
EBIT growth 1Y1143.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year248.89%
EBIT Next 3Y103.9%
EBIT Next 5YN/A
FCF growth 1Y-266.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.29%
OCF growth 3YN/A
OCF growth 5YN/A
THORNE HEALTHTECH INC / THRN FAQ
What is the ChartMill fundamental rating of THORNE HEALTHTECH INC (THRN) stock?
ChartMill assigns a fundamental rating of 4 / 10 to THRN.
What is the valuation status for THRN stock?
ChartMill assigns a valuation rating of 3 / 10 to THORNE HEALTHTECH INC (THRN). This can be considered as Overvalued.
Can you provide the profitability details for THORNE HEALTHTECH INC?
THORNE HEALTHTECH INC (THRN) has a profitability rating of 4 / 10.
What is the financial health of THORNE HEALTHTECH INC (THRN) stock?
The financial health rating of THORNE HEALTHTECH INC (THRN) is 4 / 10.
Is the dividend of THORNE HEALTHTECH INC sustainable?
The dividend rating of THORNE HEALTHTECH INC (THRN) is 0 / 10 and the dividend payout ratio is 0%.